Aventic Partners
VC Fund
Zürich, Switzerland
Aventic Partners is a VC fund in Zürich focused on Health Care and Biotechnology. Aventic Partners AG is a private equity and venture capital firm specializing in direct and fund of funds investments. The firm provides growth capital, middle market, mature, buyouts, successions, management buyouts, management buyins, and mezzanine financing. It seeks to invest in biotechnology, micro technology, microelectronics, opticalindustry, semi-conductor industry, automation, machinery, medical industry, plastics industry, information technology, software, and electronics sectors. The firm prefers to invest in companies based in Switzerland. It typically invests between CHF0.5 million ($0.43 million) and CHF5 million ($4.31 million) per investment in mezzanine financing for four to seven years. The firm makes growth capital and successions investments in companies with revenues between CHF2 million ($1.72 million) and CHF30 million ($25.76 million). Aventic Partners AG was founded in 1999 and is based in Zurich, Switzerland.
- Total investments:
- 5
- Last investment:
- Lead investor:
- 20%
Last updated:
For AI agents: llms.txt
Industries Aventic Partners invests in
Stages Aventic Partners invests in
Countries Aventic Partners invests in
Investment Focus
Industry
- Health Care 2 (40%)
- Biotechnology 2 (40%)
- Pharmaceutical 2 (40%)
- Video 1 (20%)
- Medical 1 (20%)
Stage
- Series B 3 (60%)
- Series C 1 (20%)
Country
- Switzerland 3 (60%)
- United States 1 (20%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Arktis Radiation Detectors
|
Arktis Radiation Detectors Ltd has developed a platform technology for detecting ionizing radiation using compressed noble-gas. The technology's unique capabilities for direct fast neutron detection and gamma radiation detection enable several novel applications in numerous vertical markets. | $10M / Series B / Jan 05, 2017 | |
SpotLife
|
SpotLife is the first company to bring Personal Video Broadcasting to the mainstream with a fun, easy and comprehensive solution. Using SpotLife's free service, anyone with a PC, Internet video camera and dial-up Internet connection can broadcast live or pre-recorded video with audio utilizing "point, click and broadcast" simplicity. | $30M / Series C / Dec 11, 2000 | |
Arpida AG
|
Arpida AG is a biopharmaceutical company that focused on the discovery and development of novel products for the treatment of bacterial infections. | $46.6M / Series B / Oct 23, 2000 | |
Cytos
|
Cytos is a public biopharmaceutical company focused on the development of targeted immunotherapies with a VLP B-cell vaccines platform and ongoing preclinical development programs based on the platform. | $32M / Series B / Jul 26, 2000 | |
|
SpotLife
|
SpotLife is the first company to bring Personal Video Broadcasting to the mainstream with a fun, easy and comprehensive solution. Using SpotLife's free service, anyone with a PC, Internet video camera and dial-up Internet connection can broadcast live or pre-recorded video with audio utilizing "point, click and broadcast" simplicity. | $25M / Series C / Jul 18, 2000 |
Co-Investors
Atlas Venture
2 deals together
HealthCap
2 deals together
Logitech
2 deals together
3i Group
1 deal together
Alta Berkeley Venture Partners
1 deal together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Aventic Partners invest in?
Aventic Partners invests primarily in Health Care, Biotechnology and Pharmaceutical startups, most often at Series B and Series C stage. Most of the 5 investments tracked by Shizune back companies in Switzerland. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Aventic Partners last invest?
The most recent investment recorded for Aventic Partners closed in Jan 2017. Shizune tracks 5 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
